WO2023049696A1 - Méthylation de 2-chloro-6-fluorophénol - Google Patents
Méthylation de 2-chloro-6-fluorophénol Download PDFInfo
- Publication number
- WO2023049696A1 WO2023049696A1 PCT/US2022/076700 US2022076700W WO2023049696A1 WO 2023049696 A1 WO2023049696 A1 WO 2023049696A1 US 2022076700 W US2022076700 W US 2022076700W WO 2023049696 A1 WO2023049696 A1 WO 2023049696A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- compound
- mixture
- activated mixture
- aqueous layer
- Prior art date
Links
- QIAQIYQASAWZPP-UHFFFAOYSA-N 2-chloro-6-fluorophenol Chemical compound OC1=C(F)C=CC=C1Cl QIAQIYQASAWZPP-UHFFFAOYSA-N 0.000 title description 4
- 230000011987 methylation Effects 0.000 title description 2
- 238000007069 methylation reaction Methods 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 63
- 239000000203 mixture Substances 0.000 claims abstract description 57
- 150000001875 compounds Chemical class 0.000 claims abstract description 42
- 239000010410 layer Substances 0.000 claims abstract description 31
- 238000006243 chemical reaction Methods 0.000 claims abstract description 22
- 239000012022 methylating agents Substances 0.000 claims abstract description 22
- 239000003444 phase transfer catalyst Substances 0.000 claims abstract description 21
- 239000003960 organic solvent Substances 0.000 claims abstract description 18
- 239000003513 alkali Substances 0.000 claims abstract description 17
- 239000002585 base Substances 0.000 claims abstract description 17
- 239000012044 organic layer Substances 0.000 claims abstract description 17
- 230000004913 activation Effects 0.000 claims abstract description 15
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- 150000001447 alkali salts Chemical class 0.000 claims abstract description 11
- 239000007864 aqueous solution Substances 0.000 claims abstract description 10
- 239000006227 byproduct Substances 0.000 claims abstract description 9
- 239000007788 liquid Substances 0.000 claims abstract description 9
- 239000000047 product Substances 0.000 claims abstract description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Natural products CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 20
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 claims description 11
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 7
- -1 phosphonium halide Chemical class 0.000 claims description 7
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 6
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 6
- UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 5
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical group [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 claims description 5
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 claims description 4
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 claims description 4
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 claims description 4
- IEJIGPNLZYLLBP-UHFFFAOYSA-N dimethyl carbonate Chemical compound COC(=O)OC IEJIGPNLZYLLBP-UHFFFAOYSA-N 0.000 claims description 4
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 claims description 4
- MBXNQZHITVCSLJ-UHFFFAOYSA-N methyl fluorosulfonate Chemical compound COS(F)(=O)=O MBXNQZHITVCSLJ-UHFFFAOYSA-N 0.000 claims description 4
- OIRDBPQYVWXNSJ-UHFFFAOYSA-N methyl trifluoromethansulfonate Chemical compound COS(=O)(=O)C(F)(F)F OIRDBPQYVWXNSJ-UHFFFAOYSA-N 0.000 claims description 4
- 125000003944 tolyl group Chemical group 0.000 claims description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 3
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 3
- 150000003983 crown ethers Chemical class 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 claims description 3
- 229920000570 polyether Polymers 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 239000008096 xylene Substances 0.000 claims description 3
- 159000000000 sodium salts Chemical class 0.000 claims description 2
- 229930192334 Auxin Natural products 0.000 description 7
- 239000002363 auxin Substances 0.000 description 7
- 238000000926 separation method Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 4
- 238000004817 gas chromatography Methods 0.000 description 3
- 239000004009 herbicide Substances 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- FAKJFAMIABOKBW-UHFFFAOYSA-N 1-(2,4-dichloro-5-fluorophenyl)ethanone Chemical compound CC(=O)C1=CC(F)=C(Cl)C=C1Cl FAKJFAMIABOKBW-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 238000010923 batch production Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000010924 continuous production Methods 0.000 description 2
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- UMWHJMRXMFRYCL-UHFFFAOYSA-N 1,2-dichloro-3-fluoro-4-methoxybenzene Chemical compound COC1=C(F)C(Cl)=C(Cl)C=C1 UMWHJMRXMFRYCL-UHFFFAOYSA-N 0.000 description 1
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 1
- PCHPYNHSMSAJEU-UHFFFAOYSA-N 3-chloro-2-fluorophenol Chemical compound OC1=CC=CC(Cl)=C1F PCHPYNHSMSAJEU-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000005563 Halauxifen-methyl Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- HTZCNXWZYVXIMZ-UHFFFAOYSA-M benzyl(triethyl)azanium;chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC1=CC=CC=C1 HTZCNXWZYVXIMZ-UHFFFAOYSA-M 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- WNZCDFOXYNRBRB-UHFFFAOYSA-N florpyrauxifen-benzyl Chemical group COC1=C(Cl)C=CC(C=2C(=C(N)C(Cl)=C(C(=O)OCC=3C=CC=CC=3)N=2)F)=C1F WNZCDFOXYNRBRB-UHFFFAOYSA-N 0.000 description 1
- KDHKOPYYWOHESS-UHFFFAOYSA-N halauxifen-methyl Chemical group NC1=C(Cl)C(C(=O)OC)=NC(C=2C(=C(OC)C(Cl)=CC=2)F)=C1 KDHKOPYYWOHESS-UHFFFAOYSA-N 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001035 methylating effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- SIOXPEMLGUPBBT-UHFFFAOYSA-M picolinate Chemical compound [O-]C(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-M 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
Definitions
- the method comprises combining an organic liquid comprising a compound of formula (II) (shown below) and an aqueous solution comprising an alkali base at 20-40 °C to form an organic layer comprising chlorobenzene and an aqueous layer comprising an alkali salt of the compound of formula (II).
- the organic layer and the aqueous layer are separated, and the aqueous layer is combined with a phase transfer catalyst and an organic solvent under activation conditions to form an activated mixture.
- the activated mixture and a methylating agent e.g, dimethyl sulfate
- a product mixture comprising the compound of formula (I) and by-products.
- the method comprises combining an organic liquid comprising a compound of formula (II) (shown below) and an aqueous solution comprising an alkali base at 20-40 °C to form an organic layer comprising chlorobenzene and an aqueous layer comprising an alkali salt of the compound of formula (II).
- the organic layer and the aqueous layer are separated, and the aqueous layer is combined with a phase transfer catalyst and an organic solvent under activation conditions to form an activated mixture.
- the activated mixture and a methylating agent e.g, dimethyl sulfate
- a product mixture comprising the compound of formula (I) and by-products.
- the compound of formula (I) may be herbicidal in nature, it is particularly useful as an intermediate for production of herbicides.
- the compound of formula (I) can be utilized to manufacture certain synthetic auxins, more particularly, certain pyridine-containing auxins.
- the compound of formula (I) can be a building block in the manufacture of halauxifen-methyl, florpyrauxifen-benzyl, and cyanomethyl 4-amino-3-chloro-5-fluoro-6-(7-fluoro-lH-indo-l-6-yl)pyridine-2-carboxylate.
- the compound of formula (I) can be reacted with other intermediates to form a mixture containing certain synthetic auxin herbicides such as the ones described previously, which can then be purified.
- the compound of formula (II) is 2-chloro-6-fluorophenol (CAS 2040-90-6).
- the amount of organic liquid to the amount of aqueous solution may be any suitable ratio of amounts, generally depending on the concentration of the reactants present in each.
- the amount of aqueous solution will depend on the concentration of alkali base present therein, which will depend on the concentration of the compound of formula (II) present in the organic liquid.
- any suitable alkali base may be utilized in the methods described herein. Suitable alkali bases react with the compound of formula (II) to substitute the hydrogen of the -ol group with an alkali metal ion.
- the alkali base is selected from sodium hydroxide and potassium hydroxide. In certain embodiments of the methods provided herein, the alkali base is sodium hydroxide. In certain embodiments of the methods provided herein, the alkali base is potassium hydroxide. In certain embodiments of the methods provided herein, the alkali base is present in the aqueous solution at a concentration of from about 3 wt% to about 50 wt%.
- the alkali base is present in the aqueous solution in an amount sufficient to provide an excess of equivalents as compared to the amount of the compound of formula (II) present in the organic liquid.
- enough alkali base should be present to drive the compound of formula (II) to its corresponding alkali salt.
- the amount of alkali base in the aqueous solution is from about 1.1 to about 5 equivalents as compared to the amount of the compound of formula (II) present in the organic liquid.
- the layers are separated, and the aqueous layer containing an alkali salt of the compound of formula (II) is processed further. Separation of the layers is performed as done in the art routinely, e.g., via gravitational separation or membrane phase separation. Separation of the layers can be carried out by one skill in the art without undue experimentation.
- activation conditions are utilized herein to describe, e.g., conditions suitable to allow for a reaction between certain molecules.
- activation conditions are conditions such that one or more ingredients present in a mixture would react in the presence of, e.g., a methylating agent.
- the compound of formula (II), present in the aqueous layer when combined with suitable amounts of a phase transfer catalyst and an organic solvent and at physical conditions (e.g., temperature, pressure, etc.) suitable to react with a methylating agent, should a methylating agent be introduced into the mixture, such a mixture is an “activated mixture.”
- the activation conditions utilized to form an activated mixture include heating the combined aqueous layer, phase transfer catalyst, and organic solvent. Without wishing to be bound by theory, it is believed that activating the mixture, e.g., via heating, may provide improved chemical reaction kinetics as compared to in the absence thereof.
- activation conditions comprise heating the mixture to a temperature of from about 60 °C to about 180 °C for from about 0.1 to about 5 hours, to form an activated mixture. In certain embodiments of the methods provided herein, activation conditions comprise heating the mixture to a temperature of from about 95 °C to about 115 °C for from about 0.5 to about 2 hours, to form an activated mixture.
- the activated mixture is allowed to cool.
- the term “allowed to cool” encompasses both passive (e.g., mere dissipation of heat) and active (e.g., driving cooling via refrigeration) cooling.
- the activated mixture is allowed to cool to a temperature of from about 0 °C to about 90 °C.
- the phase transfer catalyst may be any suitable phase transfer catalyst.
- a suitable phase transfer catalyst is a phase transfer catalyst that allows a reaction between the alkali salt of formula (II) to react to form the compound of formula (I) at reaction conditions in the presence of dimethyl sulfate.
- phase transfer catalysts include, but are not limited to, a crown ether, a phosphonium halide, a polyether, a phosphazenium salt, and/or a tetra- substituted ammonium halide.
- the phase transfer catalyst is selected from tetrabutyl ammonium bromide; N-benzyl-N,N-diethylethanaminium chloride; 18-crown-6; and combinations thereof.
- the phase transfer catalyst is tetrabutyl ammonium bromide.
- the phase transfer catalyst is present in the activated mixture at a concentration of from about 0.001 to about 3 wt%.
- an organic solvent is utilized in the methods provided herein to dissolve all reacting species and provide a reasonably homogeneous reacting environment.
- any suitable organic solvent may be utilized.
- the organic solvent is selected from toluene, xylene, cyclohexane, methyl cyclohexane, methyl ethyl ketone, heptane, pentane, and combinations thereof.
- the organic solvent is toluene.
- the organic solvent is present in the activated mixture at a concentration of from about 10 to about 90 wt%.
- the activated mixture is combined with a methylating agent under reaction conditions.
- the methylating agent can be any suitable methylating agent at a suitable concentration and purity.
- the methylating agent can be present in a solution comprising the methylating agent, an organic solvent, and trace impurities.
- suitable methylating agents include but are not limited to dimethyl sulfate (“DMS”), iodomethane, dimethyl carbonate, tetramethylammonium chloride, methyl trifiate, diazomethane, methyl fluorosulfonate, and combinations thereof.
- the methylating agent is selected from DMS, iodomethane, dimethyl carbonate, tetramethylammonium chloride, methyl trifiate, diazomethane, methyl fluorosulfonate, and combinations thereof. In certain embodiments of the methods provided herein, the methylating agent is DMS.
- the concentration of methylating agent added to the activated mixture drives the reaction of the alkali salt of the compound of formula (II) to proceed to the compound of formula (I), which is desired.
- the combining of the activated mixture and the methylating agent is carried out at a temperature of from about 0 °C to about 90 °C.
- the reaction conditions comprise adding the methylating agent to the activated mixture under cooling at a rate of from about 1 g/L of activated mixture per minute to about 20 g/L of activated mixture per minute.
- the product mixture can be purified as may be necessary so as to remove a portion of the reaction by-products.
- the methods provided herewith may include the further process step of washing, filtering (membrane or otherwise), crystallizing, separating gravitationally, and/or any other purification step known in the art and relevant to purifying the product mixture, or sub-components thereof.
- the method is carried out as a batch process. In certain embodiments of the methods provided herewith, the method is carried out as a semi -batch (i.e., semi-continuous) process. In certain embodiments of the methods provided herewith, the method is carried out as a continuous process.
- Each type of process e.g, batch, semi-batch, continuous
- a batch or semi-batch process perhaps would allow for versatility in the use of capital equipment.
- a continuous process once steady state is reached, may provide advantages in equipment sizing, efficiency, control, and reliability.
- (C) The aspect of claim (B), wherein the purifying comprises at least one of washing, filtering, crystallizing, and separating gravitationally.
- (D) The aspect of any one of (A)-(C), wherein the alkali base is sodium hydroxide, potassium hydroxide, or a combination thereof.
- phase transfer catalyst is selected from a crown ether, a phosphonium halide, a polyether, a phosphazenium salt, and/or a tetrasubstituted ammonium halide.
- phase transfer catalyst is tetrabutyl ammonium bromide.
- reaction conditions comprise adding the dimethyl sulfate to the activated mixture under cooling and at a rate of from about 1 g/L of activated mixture/minute to about 20 g/L of activated mixture/minute.
- (M) The aspect of any one of (A)-(L), wherein the methylating agent is selected from dimethyl sulfate (“DMS”), iodomethane, dimethyl carbonate, tetramethylammonium chloride, methyl trifiate, diazomethane, methyl fluorosulfonate, and combinations thereof.
- DMS dimethyl sulfate
- iodomethane dimethyl carbonate
- tetramethylammonium chloride methyl trifiate
- diazomethane diazomethane
- fluorosulfonate and combinations thereof.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
L'invention concerne un procédé de formation d'un composé de formule (I) (voir ci-dessous). Le procédé comprend la combinaison d'un liquide organique comprenant un composé de formule (II) (représenté ci-après) et une solution aqueuse comprenant une base alcaline à 20-40 °C pour former une couche organique comprenant du chlorobenzène et une couche aqueuse comprenant un sel alcalin du composé de formule (II). La couche organique et la couche aqueuse sont séparées, et la couche aqueuse est combinée avec un catalyseur de transfert de phase et un solvant organique dans des conditions d'activation pour former un mélange activé. Le mélange activé et un agent de méthylation sont combinés dans des conditions de réaction pour former un mélange de produits comprenant le composé de formule (I) et des sous-produits.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163246336P | 2021-09-21 | 2021-09-21 | |
US63/246,336 | 2021-09-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023049696A1 true WO2023049696A1 (fr) | 2023-03-30 |
Family
ID=83689960
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2022/076700 WO2023049696A1 (fr) | 2021-09-21 | 2022-09-20 | Méthylation de 2-chloro-6-fluorophénol |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2023049696A1 (fr) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007034325A1 (fr) * | 2005-09-21 | 2007-03-29 | Pfizer Limited | Derives de carboxamide en tant qu'antagonistes de recepteur muscarinique |
-
2022
- 2022-09-20 WO PCT/US2022/076700 patent/WO2023049696A1/fr unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007034325A1 (fr) * | 2005-09-21 | 2007-03-29 | Pfizer Limited | Derives de carboxamide en tant qu'antagonistes de recepteur muscarinique |
Non-Patent Citations (1)
Title |
---|
CAS, no. 2040-90-6 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1856024A1 (fr) | Procede de fabrication de biphenyls substitues | |
US20040106818A1 (en) | Process for the preparation of cyclohexanol derivatives | |
WO2023049696A1 (fr) | Méthylation de 2-chloro-6-fluorophénol | |
EP1985610A1 (fr) | Procédé amélioré de production d'un dérivé de nitro-iso-urée | |
JP4712320B2 (ja) | 2−オキソ−1−フェニル−3−オキサビシクロ[3.1.0]ヘキサンの製造方法 | |
CN107353217B (zh) | 一种邻氨基苯甲酸酯及酰胺类化合物的制备方法 | |
JP2889231B2 (ja) | 複素環系を含む芳香族化合物の製造方法 | |
HU207718B (en) | Process for producing 3,5,6-trichloropyridin-2-ol | |
CN113039175A (zh) | 芳基磺酰基丙烯腈的制备方法 | |
KR101856566B1 (ko) | 4'-히드록시-4-비페닐카르복실산의 신규 제조 방법 | |
JP4220619B2 (ja) | 炭酸インデンの製造方法 | |
JP4138067B2 (ja) | メチン誘導体の製造方法 | |
CN107438594B (zh) | 一种用于合成环酰胺的有效的工艺 | |
US6051714A (en) | Processes for dechlorinating pyridines | |
JP4032861B2 (ja) | β−オキソニトリル誘導体又はそのアルカリ金属塩の製法 | |
JP4335529B2 (ja) | ジヒドロピロンの連続的製造方法 | |
JP2016169192A (ja) | 7−オクテニルハライドの製造方法 | |
WO1999044969A1 (fr) | Techniques permettant d'effectuer de maniere hautement selective une o-alkylation de composes d'amide a l'aide de sels de cuivre | |
JP4710140B2 (ja) | ピロリン誘導体の製造法 | |
JPH04264075A (ja) | チアゾリジン−2−オン誘導体の製造方法 | |
JP2008503452A (ja) | 無水アルキルホスホン酸類でのアルデヒドオキシム類から水の脱離によるニトリル類の製造方法 | |
JP3845786B2 (ja) | ジフェニルホスホリルアジドの製造方法 | |
JP5234344B2 (ja) | パラジウムヘキサフルオロアセチルアセトナートの単離方法。 | |
JP2003238500A (ja) | 含フッ素3級アミン化合物及び含フッ素4級アンモニウム塩の製造方法 | |
WO2004035529A1 (fr) | Procede de production de n-(2-amino-1,2-dicyanovinyl)formamidine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22787139 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |